Pupillary Pathways

Follow Us

2 New Topical Glaucoma Medications to Watch Out For

Posted by Amanda Dexter on Oct 4, 2018 8:08:05 AM

For several years we haven't had any new topical glaucoma medications come to the market, but this year we have 2 new drugs! Both have something new to offer for the treatment and management of our glaucoma patients. Check them out!

Read More

Topics: Glaucoma

Could glaucoma be a curable autoimmune disease?

Posted by Amanda Dexter on Aug 28, 2018 7:58:33 AM

Isn't it interesting that some individuals can have elevated eye pressures and never develop glaucoma? And some patients can have low eye pressures and have devastating vision loss from advanced glaucoma?

This has always been something that causes me to scratch my head and wonder what other processes could be involved in the development and progression of this disease.

Read More

Topics: Glaucoma

Triggerfish: Smart Contact Lens for Glaucoma Monitoring

Posted by Amanda Dexter on Apr 11, 2016 9:00:00 AM

Last month, the FDA (US Food and Drug Administration) granted a marketing license to a Swiss-based company called Sensimed for its smart contact lens that aims to tackle current limitations in monitoring intraocular pressure (IOP) in patients with glaucoma.

This sensor device is currently being utilized throughout Europe and has been studied in the US, but will hopefully start to be more widely available to practitioners and patients shortly for glaucoma monitoring.

Read More

Topics: Glaucoma

Topical Glaucoma Medications (Alpha-2 Agonists, CAIs, Miotics & Combo)

Posted by Amanda Dexter on Mar 3, 2016 9:00:00 AM

On Monday we reviewed the most important concepts associated with prostaglandin analogs and beta-blockers.

Today we will continue on with reviewing the mechanisms of action, dosages, side effects, contraindications, and preparations of topical alpha-2 agonists, carbonic anhydrase inhibitors, miotics, and combination medications. 

Read More

Topics: Glaucoma

Review of Topical Glaucoma Medications

Posted by Amanda Dexter on Feb 29, 2016 3:13:50 PM

Last week I attended a continuing education course in which we reviewed several difficult glaucoma patient cases. These were all patients with moderate to advanced glaucoma who showed progression and the subsequent need for adjustment of their current glaucoma treatment plans.

Additionally, most of these patients also presented with complicated medical histories, had allergies to certain classes of medications, responded poorly or ineffectively to prior topical glaucoma treatments, and had difficulties with compliance when multiple medications were needed. 

Read More

Topics: Glaucoma



Subscribe to Our Blog

New call-to-action


Popular Posts

Posts by Topic

see all

New Call-to-action